- Top 5% of respondersIterative Health is in the top 5% of companies in terms of response time to applications
- Responds within a few daysBased on past data, Iterative Health usually responds to incoming applications within a few days
- B2B
- +1
VP, Corporate Development
- $250k – $275k
- Full Time
Not Available
Alex Mimms
About the job
We are looking for a results-driven Vice President of Corporate Development to spearhead our acquisition strategy in the clinical trials market. This is a high-impact role for an ambitious leader with a background in investment banking, private equity or similar position in a fast-paced biotech company, offering the opportunity to shape our growth strategy and drive major M&A transactions. The VP of Corporate Development will be instrumental in identifying, assessing, and acquiring clinical trial sites to accelerate company expansion and enhance our position in the clinical trials space. This role is a high-visibility position designed for a high-performing leader who is eager to make a substantial impact in a rapidly growing organization.
What you’ll be doing:
- Lead Acquisitions Strategy: Drive the company’s acquisition strategy, identifying and securing high-value clinical trial sites and healthcare assets that align with long-term growth goals
- Market Insight & Target Identification: Utilize deep market expertise and analytical skills to identify acquisition targets with high potential, while remaining responsive to competitive dynamics and industry trends
- Deal Structuring, Negotiation & Execution: Take ownership of the full transaction lifecycle, from structuring deals and performing due diligence to managing financial analyses and negotiating terms, ensuring optimal deal outcomes
- Integration Planning & Execution: Work collaboratively across finance, legal and operational teams to ensure smooth post-acquisition integration, maximizing value and ensuring alignment with overarching strategic goals
- Executive Communication & Stakeholder Management: Develop and deliver compelling acquisition proposals, financial summaries, and performance reports to the executive team and board, ensuring buy-in and alignment with corporate vision
- Risk Management & Compliance: Identify, assess, and mitigate potential financial, regulatory, and operational risks associated with acquisitions
Required Skills:
- Experience in private equity or with the private equity acquisition roll-up model, with a focus on buy-and-build strategies and portfolio company growth, or similar position in healthcare
- Proven experience in managing end-to-end M&A transactions, particularly within healthcare, with a strong understanding of deal structuring, negotiation, and due diligence
- Strong negotiation skills with a track record of achieving favorable terms in high-stakes transactions
- Excellent communication skills, with the ability to manage and influence cross-functional teams and external partners
- Strategic thinker with strong analytical and problem-solving capabilities
- Desire to be wear many hats and a willingness to jump on to various projects as needed
Preferred Skills:
- Deep understanding of the healthcare sector, particularly within clinical trials, site operations, and regulatory considerations
- Familiarity with clinical trial processes, site management practices, and compliance requirements within the healthcare industry
- Previous experience with international (non-US) acquisitions, especially in EU
- MBA or equivalent degree
- Experience working in a fast growing startup
Please note: This role will be accepting applications from November 14, 2024 until November 26, 2024. Resumes will be reviewed and applicants will receive an update by 5pm ET on Thursday December 5th. Interviews will begin thereafter.
About the company
- Top 5% of respondersIterative Health is in the top 5% of companies in terms of response time to applications
- Responds within a few daysBased on past data, Iterative Health usually responds to incoming applications within a few days
- B2B
- Scale StageRapidly increasing operations